← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2016Last known activity
Aug 28, 2017
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Recent trials (2)
- NCT03280056Overall official - principal investigatorPhase 3Aug 28, 2017
- NCT02913417Lead sponsorPhase 1/Phase 2Oct 1, 2016
Details
- Last known activity
- Aug 28, 2017